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Abstract 
Objective: Chlamydia Trachomatis is becoming an increasingly large national problem with 
severe consequences on the medical health care system. Methods:  With data collected from 
County Health Ranking, with research that has been conducted at governmental and 
nongovernmental levels throughout the community, state and national level.  Increases in rates of 
chlamydia can be linked to an increased number of testing or increased accuracy of testing while 
decreased numbers of incidence can be due to low reporting from that county. Conducting 
correlation and comparison may reveal additional links to the rising rates of Chlamydia. Results: 
We found a positive correlation between rate of chlamydia and percent access to exercise 
opportunities as well as a positive comparison between 2016 and 2019 rates of Chlamydia in 
Ohio. No correlation was found between rates of chlamydia and insufficient sleep. 






Introduction/Literature Review  
Chlamydia Trachomatis is a genital tract infection with numerous consequences that poses an 
increasingly large problem in America. As the fastest growing sexually transmitted infection in 
the United States, over 1.4 million reported new cases each year, the complications are also 
increasing. 1 The rates of infection are greatest for sexually active, non-Hispanic black females 
which is nearly five times the prevalence among non-Hispanic white females. 2,3 Pelvic 
Inflammatory disease, postpartum endometritis and tubal infertility are some of the most 
common sequelae with management cost per case ranging from 163 dollars to 6,752 dollars. 4 
Ohio began to increase measures to prevent the spread of these infections with the passage of 
expediated partner therapy in 2016. 5 
Researchers have found a substantial range in cost per case of chlamydia. Differing 
management, perspectives of disease process and different screening tests all influence the 
potential cost of care for untreated Chlamydia Trachomatis infection. 4,6 Chlamydia is 
responsible for almost half of the sexually transmitted infections in people ages 14-24, but 
testing of this population group is extremely low.2,3,6 The infection can be symptomless which 
leads to problems such as pelvic inflammatory disease, post-partum endometritis, infertility and 
adverse birth outcomes which cost over 15.6 billion dollars annually. 4,7 In 2019, randomly 
testing about 300 college students from three different universities showed an unknown 
chlamydia infection rate of 5.8% in the specified population. 7  
A lot of research has been done on chlamydia, both in its acute treatment as well as treatment 
and cost of its complications. However, the correlation between increase incidence of chlamydia 
infections and access to exercise opportunities as well as the correlation between incidence of 
chlamydia and insufficient sleep have been relatively unexplored. If a negative correlation exists 
between the rate of chlamydia and access to exercise opportunities a case could be made for 
increasing exercise opportunities for teenagers in cities with uncontrollable rates of STIs. With 
hundreds of thousands of health care dollars spent on treating infections and sequelae spending a 
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few thousand dollars on playground equipment to decreased neighborhood rates could 
financially benefit a lot of cities. The possibility of a decreased rate of chlamydia infections and 
the subsequent sequelae for the cost of increased access to exercise possibilities poses an 
interesting quandary.  
 
Research Questions 
RQ 1:  What is the correlation between the rate of chlamydia and percent access to exercise 
opportunities in 2019 Ohio? 
RQ 2:  How do the rates of chlamydia change from 2016 to 2019 in Ohio? 
RQ 3:  What is the correlation between insufficient sleep and rate of chlamydia in 2019 Ohio? 
Methods 
Context/Protocol 
Data collected on Chlamydia infections in Ohio 2019 was provided by the National Center 
for HIV/AIDS, Viral Hepatitis, STD and TB Prevention. Data collected on Rates of Access to 
Exercise Opportunity was provided by The Business Analyst. Access to exercise was measured 
as the percentage of individuals who live reasonably close to a location for physical activity via a 
census. The 2019 County Health Rankings used data from 2016 for both of these measures. 
Insufficient sleep information was provided via the Behavioral Risk Factor Surveillance System 
and was measured based on survey of adults who reported less than 7 hours of sleep a night on 
average. Research was collected with governmental and nongovernmental partners at the 
community, state and national levels. Data collected for Chlamydia infections showed 
information on all peoples who are sexually active within Ohio Counties for 2019.  
Data Collection 
An increase in the number of reported cases could be due to increased incidence of disease 
by may also show an increase use of testing or increase sensitivity of the diagnostic tests. Rates 
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of Chlamydia in a given county were measures by the number of events divided by the average 
number of people who were at risk during the same time period. Communities with poor 
screening rates have the possibility of incorrectly low rates of chlamydia incidence. Data was 
excluded for counties with few than 4 cases in the given time frame.  
Data Analysis 
We conducted a Pearson correlation with the rate of chlamydia as our dependent variable and 
percent access to exercise opportunities as our independent variable in 2019 Ohio to answer 
RQ1.  
We conducted a paired sample t-test between the rates of chlamydia in 2016 as compared to 
2019 in Ohio to answer RQ2. 
We conducted a Pearson correlation with the rate of chlamydia as our dependent variable and 
insufficient sleep as our independent variable in 2019 Ohio to answer RQ3. 
Results 
 For research question 1 we are correlating rate of chlamydia with percent access to 
exercise opportunities. A Pearson correlation showed a significant correlation of p=.001 and an r 
value of .83 where as the percent access to exercise opportunities increases the rate of chlamydia 
also increases. 
Figure 1: Correlation Between Rate of Chlamydia and Percent Access to Exercise Opportunities 




For research question 2 we are comparing the rate of chlamydia between Ohio counties in 
2016 and 2019. We found that the prevalence significantly increased from 282 in 2016 to 324 in 




Table 1: Rate of Chlamydia in Ohio 
Year n Mean SD 
2016 88 282 135.7 
2019 88 324 159.7 
Statistically significantly different from 2016 (p<.001) 
 
 
For research question 3 we are correlating rate of chlamydia with insufficient sleep. A 
Pearson correlation showed that there was no significant correlation between the rate of 
chlamydia and insufficient sleep in Ohio 2019 with an r value of .27 and a p>.05. (Figure 2).  
 





My results found that there was a positive correlation between rate of chlamydia and percent 
access to exercise opportunities in Ohio 2019. There was also a statistically significant difference 
between rates of chlamydia in Ohio 2016 and 2019 that showed rates of chlamydia have been 
increasing over the course of three years. The results showed no correlation between rates of 
chlamydia and insufficient sleep in Ohio 2019. 
As previous data has shown, rates of chlamydia over the past several decades has been 
steadily increasing despite efforts to slow the progression.1,8 With increasingly concerning 
sequelae including but not limited to infertility, PID and ectopic pregnancy foremost among 
them, chlamydia has become a large concern in the health care field.1 With the consequences of 
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chlamydia increasing steadily the cost to the health care field is increasing exponentially as 
well.8 Cost analysis of the benefit of testing high risk, asymptomatic patients showed an average 
cost of $22 per person, with roughly 300,000 additional people treated each year.4,6  
With findings correlating percent access to exercise opportunities and rates of chlamydia this 
gives an opportunity to find and test high risk young adults in the community. The decrease of 
the spread of the initial disease with asymptomatic patients being treated before additional 
sequelae can lead to high cost treatments would save hundreds of thousands of dollars for the 
health care system. The unencumbered increase of chlamydia has become a national concern and 
all efforts to decrease the spread as well as decrease cost to the system should be considered. 
Conclusion 
 One of the important limitations of this paper is that the reported infections of chlamydia 
may reflect true increases in the disease but could also be reflective of expanded screening 
opportunities in the individual counties. With an increased emphasis on this case reporting from 
individual labs and providers we have improvement in the system. On the other end counties 
with low rates of chlamydia could be artificially low due to low reporting rates. Discussions for 
the future directions of this project could be additional correlations between rates of chlamydia 
and additional factors to decrease the number of asymptomatic persons needed to be tested.  
While the cost of treating ectopic pregnancies can reach upwards of $3,000 per patient the 
cost of testing asymptomatic patients is still one the health care system can ill afford; finding a 
niche of people to test to decrease the amount of people tested to decrease the average cost per 
person seems a reasonable solution. With the positive correlation between chlamydia and percent 
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access to exercise opportunities, testing high risk, young adults who frequent places of physical 
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